Spironolactone: diuretic or disease-modifying drug in heart failure with preserved ejection fraction?

Eur J Heart Fail. 2020 Sep;22(9):1611-1614. doi: 10.1002/ejhf.1979. Epub 2020 Sep 20.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Diuretics / therapeutic use
  • Heart Failure* / drug therapy
  • Hospitalization
  • Humans
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Pharmaceutical Preparations*
  • Spironolactone / therapeutic use
  • Stroke Volume

Substances

  • Diuretics
  • Mineralocorticoid Receptor Antagonists
  • Pharmaceutical Preparations
  • Spironolactone